Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 8,300 shares at $539.76 ($4.5M) on 2026-06-04, disclosed to the SEC on 2026-06-04.
Scheduled sale ($4.5M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $539.76 | 200 | $108K | 2.4% |
| 2 | $543.89 | 840 | $457K | 10.1% |
| 3 | $545.27 | 374 | $204K | 4.5% |
| 4 | $546.42 | 2,627 | $1.4M | 31.6% |
| 5 | $547.11 | 935 | $512K | 11.3% |
| 6 | $548.42 | 1,481 |
| $812K |
| 17.9% |
| 7 | $549.47 | 1,250 | $687K | 15.1% |
| 8 | $549.49 | 593 | $326K | 7.2% |
| Total | $547.07 avg | 8,300 | $4.5M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-08-06 | $4.3M | — | Filing → |